Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: A chronological and international comparative study

Japanese Journal of Clinical Oncology

Volumn 41, Issue 1, 2011, Pages 40-51

  Matsuda, Tomohiro ^a   Ajiki, Wakiko ^a   Marugame, Tomomi ^a   Ioka, Akiko ^b   Tsukuma, Hideaki ^b   Sobue, Tomotaka ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Epidemiol prevention; Epidemiology public health; Prognostic factors

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COLON CANCER; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HUMAN; JAPAN; LEUKEMIA; LIVER CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSTATE CANCER; STOMACH CANCER; TESTIS CANCER; UTERUS CANCER;

ADULT; AGE DISTRIBUTION; AGED; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIGESTIVE SYSTEM NEOPLASMS; EUROPE; FEMALE; HUMANS; JAPAN; LEUKEMIA; LYMPHATIC METASTASIS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS; PROSTATIC NEOPLASMS; REGISTRIES; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SURVIVAL RATE; TESTICULAR NEOPLASMS; UNITED STATES; UTERINE NEOPLASMS;

EID: 78650769304     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq167     Document Type: Article

References (34)

1. Sakamoto K, Machi J, Prygrocki M, Watanabe T, Hosoda S, Sugano M, et al. Comparison of characteristics and survival of colorectal cancer between Japanese-Americans in Hawaii and native Japanese in Japan. Dis Colon Rectum 2006;49:50-7.
2. Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, et al. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 2001;34:29-36.
3. Bunt AM, Hermans J, Smit VT, van de Velde CJ, Fleuren GJ, Bruijn JA. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995;13:19-25.
4. Ajiki W, Matsuda T, Sato Y, Fujita M, Yamazaki S, Murakami R, et al. A standard method of calculating survival rates in population-based cancer registries. Jpn J Cancer Clin 1998;44:981-93.
5. Ajiki W, Matsuda T, Sato Y, Fujita M, Yamazaki S, Murakami R, et al. Standard method of calculating relative survival rates in populationbased cancer registries-an investigation using stomach cancer patients. Jpn J Cancer Clin 1997;43:1005-14.
6. Oshima A, Ajiki W, Tsukuma H. Estimation of survival of cancer patients in Japan (preliminary report). In: Tajima K, Kuroishi T, Oshima A, editors. Cancer Mortality and Morbidity Statistics: Japan and the World. Tokyo: Japan Scientific Societies Press 2004;131-5.
7. Tsukuma H, Ajiki W, Ioka A, Oshima A, Research Group of Population-Based Cancer Registries of Japan. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Jpn J Clin Oncol 2006;36:602-7.
8. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 2008;38:641-8.
9. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Survival of Cancer Patients in Europe: The EUROCARE Study. Lyon: International Agency for Research on Cancer 1995
10. Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 2003;8:541-52.
11. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
12. Ioka A, Ito Y, Tsukuma H. Factors relating to poor survival rates of aged cervical cancer patients: a population-based study with the relative survival model in Osaka, Japan. Asian Pac J Cancer Prev 2009;10:457-62.
13. Farley JH, Nycum LR, Birrer MJ, Park RC, Taylor RR. Age-specific survival of women with endometrioid adenocarcinoma of the uterus. Gynecol Oncol 2000;79:86-9.
14. Sorensen JT, Gerald K, Bodensteiner D, Holmes FF. Effect of age on survival in acute leukemia. 1950-1990. Cancer 1993;72:1602-6.
15. Nielsen ME, Shariat SF, Karakiewicz PI, Lotan Y, Rogers CG, Amiel GE, et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 2007;51:699-706. discussion-8.
16. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004;126:347-51.
17. Marsit CJ, Houseman EA, Schned AR, Karagas MR, Kelsey KT. Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis 2007;28: 1745-51.
18. Ito Y, Ohno Y, Rachet B, Coleman MP, Tsukuma H, Oshima A. Cancer survival trends in Osaka, Japan: the influence of age and stage at diagnosis. Jpn J Clin Oncol 2007;37:452-8.
19. Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg 2006;30:1567-78.
20. Kawano T, Nakajima Y, Suzuki T, Haruki S, Ogiya K, Kawada K, et al. [Esophageal carcinoma - from the viewpoint of surgery]. Gan To Kagaku Ryoho 2007;34:824-30.
21. Kudo M. Early detection and curative treatment of early-stage hepatocellular carcinoma. Clin Gastroenterol Hepatol 2005;3(10 Suppl 2):S144-8.
22. Kawai M, Kuriyama S, Suzuki A, Nishino Y, Ishida T, Ohnuki K, et al. Effect of screening mammography on breast cancer survival in comparison to other detection methods: a retrospective cohort study. Cancer Sci 2009;100:1479-84.
23. Yamanaka N, Takata M, Tanaka T, Yamanaka J, Yasui C, Ando T, et al. Evolution of and obstacles in surgical treatment for hepatocellular carcinoma over the last 25 years: differences over four treatment eras. J Gastroenterol 2000;35:613-21.
24. Koike T, Yamato Y, Asamura H, Tsuchiya R, Sohara Y, Eguchi K, et al. Improvements in surgical results for lung cancer from 1989 to 1999 in Japan. J Thorac Oncol 2009;4:1364-9.
25. Sandhu A, Mundt AJ. Radiation therapy for urologic malignancies in the elderly. Urol Oncol 2009;27:643-52.
26. Nomura E, Tsukuma H, Ajiki W, Oshima A. Population-based study of relationship between hospital surgical volume and 5-year survival of stomach cancer patients in Osaka, Japan. Cancer Sci 2003;94: 998-1002.
27. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44:1345-89.
28. Parkin D, Whelan S, Ferlay J, Teppo L, Thomas D. Cancer Incidence in Five Continents, Vol. VIII. Lyon: International Agency for Research on Cancer 2002.
29. Sobin L, Wittekind C. TNM Classification of Malignant Tumours. 6th edn. New Jersey: John Wiley & Sons 2002.
30. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730-56.
31. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2009;11:165-73.
32. Moore MA, Shin HR, Curado MP, Sobue T. Establishment of an Asian Cancer Registry Network-problems and perspectives. Asian Pac J Cancer Prev 2008;9:815-32.
33. Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. Should we use incidence, survival or mortality to assess breast cancer trends in European women? Nat Clin Pract Oncol. 2006;3:228-9.
34. Matsuda T, Marugame T, Kamo KI, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2009;39:850-8.